BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 20193031)

  • 1. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptor-ligand analysis of killer cell Ig-like receptor in Jiangsu Han population].
    Jiang LX; Xu LH; Qi CP; Wang YF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):863-5. PubMed ID: 22863597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
    Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.
    Du Z; Gjertson DW; Reed EF; Rajalingam R
    Immunogenetics; 2007 Jan; 59(1):1-15. PubMed ID: 17103212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
    Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of KIR genes in the Iranian population.
    Tajik N; Shahsavar F; Mousavi T; Radjabzadeh MF
    Tissue Antigens; 2009 Jul; 74(1):22-31. PubMed ID: 19392787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.
    Shastry A; Sedimbi SK; Rajalingam R; Rumba I; Kanungo A; Sanjeevi CB
    Ann N Y Acad Sci; 2008 Dec; 1150():133-8. PubMed ID: 19120281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.
    Rudnick CC; Franceschi DS; Marangon AV; Guelsin GA; Sell AM; Visentainer JE
    Hum Immunol; 2008 Dec; 69(12):872-6. PubMed ID: 18848853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.
    Hasenkamp J; Borgerding A; Uhrberg M; Falk C; Chapuy B; Wulf G; Jung W; Trümper L; Glass B
    Scand J Immunol; 2008 Mar; 67(3):218-29. PubMed ID: 18226015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.
    Mousavi T; Shahsavar F; Farnia P; Tajik N; Soofi M
    Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):189-94. PubMed ID: 21891825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis.
    Miyashita R; Tsuchiya N; Yabe T; Kobayashi S; Hashimoto H; Ozaki S; Tokunaga K
    Arthritis Rheum; 2006 Mar; 54(3):992-7. PubMed ID: 16508981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
    Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
    Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].
    Zhang HQ; Zhao JJ; Zhao YR; Guan QB; Gao L; Song HD
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):699-701. PubMed ID: 19664392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor systems controlling natural killer cell function are genetically stratified in Europe.
    Guinan KJ; Cunningham RT; Meenagh A; Dring MM; Middleton D; Gardiner CM
    Genes Immun; 2010 Jan; 11(1):67-78. PubMed ID: 19693090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
    Kanga U; Mourya M; Seth T; George J; Sood P; Sharma R; Saxena A; Mehra NK
    Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.